by gkuhn | May 27, 2022 | CPCCRN Study Updates
CPCCRN is pleased to announce our newest study, the Personalized Immunomodulation in Pediatric Sepsis-Induced MODS Trial, or PRECISE. The PRECISE Trial, funded by the Eunice Kennedy Shriver National Institute of Child Health and Human Development, will begin enrolling...
